Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label trial of phosphate hemofiltration replacement solution in CRRT
CTR20240020Phase 2Completed
- Sponsor
- Qingshan Likang Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phosphate in acute kidney failure (AKF), critical illness, sponsored by Qingshan Likang Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
phosphate
03
Conditions
acute kidney failure (AKF)critical illness
Beyond the preview
Go deeper on CTR20240020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240020.